ConvaTec Group (LON:CTEC – Get Free Report) had its price target dropped by research analysts at Royal Bank of Canada from GBX 320 ($4.12) to GBX 305 ($3.92) in a report released on Wednesday, LSE.Co.UK reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target points to a potential upside of 29.35% from the stock’s previous close.
A number of other equities research analysts have also issued reports on the company. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 310 ($3.99) price target on shares of ConvaTec Group in a research report on Tuesday, June 11th. JPMorgan Chase & Co. reduced their price target on ConvaTec Group from GBX 323 ($4.15) to GBX 290 ($3.73) and set an “overweight” rating on the stock in a research report on Wednesday. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of GBX 302.50 ($3.89).
View Our Latest Research Report on CTEC
ConvaTec Group Trading Down 0.6 %
ConvaTec Group Company Profile
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Read More
- Five stocks we like better than ConvaTec Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- P/E Ratio Calculation: How to Assess Stocks
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.